Skip to main content
Premium Trial:

Request an Annual Quote

Proteomics Shop Miraculins, University of Manitoba Pen Research Collaboration

NEW YORK, Feb. 6 - Canadian proteomics company Miraculins has signed a research agreement with the University of Manitoba to use the school's time-of-flight mass-spectrometry technology, the company said recently.


The technology, Qstar, was developed by UM researchers Kenneth Standing and Werner Ens, with help from MDS-Sciex's quadrupole technology.


No further information was provided.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.